‘There’s no stool left – just stool bugs. These people are not eating poop,’ and there are no smelly burps because the contents aren’t released until they’re well past the stomach, Louie said. Days before starting the treatment, patients are given an antibiotic to kill the C-diff. On the morning of the treatment, they have an enema so ‘the new bacteria coming in have a clean slate,’ Louie said. It takes 24 to 34 capsules to fit the bacteria needed for a treatment, and patients down them in one sitting. The pills make their way to the colon and seed it with the normal variety of bacteria. Louie described 27 patients treated this way on Thursday at IDWeek, an infectious diseases conference in San Francisco. All had suffered at least four C-diff infections and relapses, but none had a recurrence after taking the poop pills. Margaret Corbin, 69, a retired nurse’s aide from Calgary, told of the misery of C-diff. ‘It lasted for two years. It was horrible. I thought I was dying. I couldn’t eat. Every time I ate anything or drank water I was into the bathroom,’ she said.
Indian doctors less likely to be promoted to senior hospital jobs in UK: Study
PTI The BMJ Careers journal found that in 2012, 13.8 percent of white applicants to senior hospital doctor jobs inEngland were successful in securing the role they applied for,compared with just 4.8 per cent of doctors from ethnicminority backgrounds. Black doctors were the least likely to secure consultant, specialist or other senior doctor roles, with a success rateof only 2.7 per cent. Asian and British Asian doctors had a mildly better ratioat 5.72 per cent, with a total of 2,514 appointed last year.Indian-origin doctors have long been seen as the back-boneof the NHS with over 25,000 practicing in the UK. But concernsaround discrimination within the countrys health service hadrecently forced the General Medical Council (GMC),the doctorswatchdog in the UK, to investigate. Another paper, also published by the British MedicalJournal, found that ethnic minority doctors were much morelikely to fail the exam required to practice as a generalpractitioner (GP). The researchers said they cannot exclude subjective biasowing to racial discrimination in the marking of the clinicalskills assessment as a reason for the discrepancy. The paper follows a GMC review of the exam, which is runby the Royal College of General Practitioners (RCGP),following concerns about failure rates among doctors whoqualified outside the UK, as well as among UK-trained doctorsfrom black or other ethnic minority backgrounds. In his report for the GMC, Aneez Esmail, professor ofgeneral practice at the University of Manchester, said moreneeded to be done to acknowledge that candidates trainedoverseas may require more training and support. Ethnic minority GP candidates trained in the UK were four times more likely to fail than their white UK-trainedcolleagues at the first attempt, but these differencesdisappeared at the second attempt, Esmail found. According to RCGP figures, the failure rate for Britishmedical graduates of South Asian origin is 17.5 per cent andfor a black candidate 24.4 per cent, compared with 5.8 percent for a white candidate. The British Association of Physicians of Indian Origin(BAPIO), which represents Indian-origin doctors working in theUK, has been campaigning for a probe into the disparity inresults for over two years ago. We want fairness and equal treatment for the IMG(international medical graduate) trainees. For the qualifyingbodies, it should be an extremely worrying point if a largenumber of trainees from a particular background are failing,despite most successfully completing three years in trainingunder supervision and actually servicing live patients, saidBAPIO president Ramesh Mehta, himself an examiner in the UK. The RCGP has denied allegations of bias and welcomed thereview.
Placebos Prescribed By More Than Three-Quarters Of UK Doctors, Survey Finds
About 77 percent of doctors said they used some kind of placebo treatment every week; more than 80 percent of them said their use in some circumstances was ethical. The “placebo effect” treatments included unnecessary physical exams, joint injections, physical therapy, peppermint pills for a sore throat and antibiotics for infections where they would not be effective. Dr. Tony Calland, chairman of the British Medical Association’s Ethics Committee, said he was disappointed by the findings. “Prescribing something that you know is of no value is not ethical,” he said. A previous study found about half of U.S. doctors regularly give their patients treatments that probably won’t work without telling them, and the practice has been reported elsewhere, including Canada, Denmark and Switzerland. The American Medical Association says physicians may only use placebos if the patient is aware. In 2011, the German Medical Association recommended doctors use fake pills and other placebo treatments more often and said patients didn’t necessarily need to be told. Some small studies have found dummy pills work even when patients are explicitly told what they’re getting and others have documented the fake treatments can spark a biological effect in the body. “For illnesses where there is no truly effective treatment, a placebo or alternative therapy is a fine thing to do,” said Dr. Walter Brown, a clinical professor of psychiatry at Brown University and author of a recent book on placebos. He was not connected to the new study. Brown said doctors weren’t obligated to use the word “placebo” when prescribing the treatment.